EA2185
OPEN TO ACCRUAL
Pancreatic Cyst Surveillance
EA2192
OPEN TO ACCRUAL
APOLLO - PII Adjuvant Olaparib vs Placebo for Resected Pancreatic Cancer with BRCA1,2 or PALB2
UW24051
OPEN TO ACCRUAL
Phase 1 and 2 Basket Study of MK-2870 in GI Cancers
UW26022
OPEN TO ACCRUAL
Ph III Chemo + or - INCB161734 for KRAS G12D-Mutated Metastatic PDAC
UW26051
OPEN TO ACCRUAL
A Phase 2 Study of VS-7375 in Patients with KRAS G12D-Mutated Pancreatic Cancer
UW26057
OPEN TO ACCRUAL
Ph3 Randomized Atebimetinib + modified Gem + nab-Pac vs. standard Gem + nab-Pac in mets PDAC